Unknown

Dataset Information

0

Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition.

ABSTRACT: The accumulation of brain amyloid ? (A?) is one of the main pathological hallmarks of Alzheimer's disease (AD). However, the role of brain amyloid deposition in the development of AD and the genetic variants associated with this process remain unclear. In this study, we sought to identify associations between A? deposition and an a priori evidence based set of 1610 genetic markers, genotyped from 505 unrelated individuals (258?A?+ and 247?A?-) enrolled in the Australian Imaging, Biomarker & Lifestyle (AIBL) study. We found statistically significant associations for 6 markers located within intronic regions of 6 genes, including AC103796.1-BDNF, PPP3R1, NGFR, KL, ABCA7 & CALHM1. Although functional studies are required to elucidate the role of these genes in the accumulation of A? and their potential implication in AD pathophysiology, our findings are consistent with results obtained in previous GWAS efforts.

SUBMITTER: Vacher M 

PROVIDER: S-EPMC6863876 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The accumulation of brain amyloid β (Aβ) is one of the main pathological hallmarks of Alzheimer's disease (AD). However, the role of brain amyloid deposition in the development of AD and the genetic variants associated with this process remain unclear. In this study, we sought to identify associations between Aβ deposition and an a priori evidence based set of 1610 genetic markers, genotyped from 505 unrelated individuals (258 Aβ+ and 247 Aβ-) enrolled in the Australian Imaging, Biomarker & Life  ...[more]

Similar Datasets

Unknown Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer's Disease Patients.
| S-EPMC7399638 | biostudies-literature
Transcriptomics Genetic variability in response to Amyloid beta deposition influences Alzheimer's disease risk
2019-10-31 | GSE137313 | GEO
Unknown Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.
| S-EPMC2700302 | biostudies-literature
Unknown Genetic variability in response to amyloid beta deposition influences Alzheimer's disease risk.
| S-EPMC7145452 | biostudies-literature
Unknown Whole brain imaging reveals distinct spatial patterns of amyloid beta deposition in three mouse models of Alzheimer's disease.
| S-EPMC8026112 | biostudies-literature
Unknown Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.
| S-EPMC4196723 | biostudies-literature
Proteomics Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain
2017-08-28 | PXD006552 | Pride
Unknown Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.
| S-EPMC5572664 | biostudies-literature
Proteomics Amyloid-beta Citrullination in Alzheimer's Disease
2021-11-24 | PXD025620 | Pride
Unknown Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer's disease.
| S-EPMC8567578 | biostudies-literature